atomoxetine hydrochloride has been researched along with nortriptyline in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Banaschewski, T; Heise, CA; Himpel, S; Rothenberger, A | 1 |
| Adli, M; Bauer, M; Burghardt, R; Pilhatsch, MK; Wandinger, KP | 1 |
| Guo, B; He, MM; Li, C; Liu, H; Shen, H; Wang, L; Wrighton, SA | 1 |
| Bangerl, W; Friedrich, M; Kienbacher, C; Pellegrini, E; Scheidinger, H; Vesely, C; Wiesegger, G | 1 |
| Ebbert, JO; Elrashidi, MY | 1 |
| Bastiaens, L; Galus, J; Scott, O | 1 |
3 review(s) available for atomoxetine hydrochloride and nortriptyline
| Article | Year |
|---|---|
The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Adult; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clonidine; Desipramine; Guanfacine; Humans; Imipramine; Nortriptyline; Propylamines | 2005 |
[Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].
Topics: Adrenergic Uptake Inhibitors; Antipsychotic Agents; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Comorbidity; Contraindications; Cross-Sectional Studies; Drug Therapy, Combination; Humans; Mood Disorders; Nortriptyline; Practice Guidelines as Topic; Propylamines; Randomized Controlled Trials as Topic; Tic Disorders | 2007 |
Emerging drugs for the treatment of tobacco dependence: 2014 update.
Topics: Atomoxetine Hydrochloride; Benzazepines; Bupropion; Clinical Trials as Topic; Clonidine; Humans; Mecamylamine; Nicotine; Nortriptyline; Propylamines; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2014 |
5 other study(ies) available for atomoxetine hydrochloride and nortriptyline
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Augmentation with atomoxetine in treatment-resistant depression with psychotic features. A case report.
Topics: Atomoxetine Hydrochloride; Clozapine; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Middle Aged; Nortriptyline; Propylamines; Psychotic Disorders; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index | 2006 |
Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17.
Topics: Atomoxetine Hydrochloride; Cocaine; Codeine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Debrisoquin; Dextromethorphan; Enzyme Inhibitors; Ethanolamines; Fluoxetine; Humans; Hydroxylation; Imipramine; Kinetics; Microsomes; Molecular Structure; Nortriptyline; Polymorphism, Single Nucleotide; Propylamines; Quinidine; Recombinant Proteins; Thioridazine; Tramadol | 2007 |
Treatment of Adult ADHD without Stimulants: Effectiveness in A Dually Diagnosed Correctional Population.
Topics: Adrenergic Agents; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Comorbidity; Diagnosis, Dual (Psychiatry); Female; Follow-Up Studies; Guanfacine; Humans; Male; Mental Disorders; Nortriptyline; Outcome Assessment, Health Care; Prisoners; Retrospective Studies; Severity of Illness Index; Substance-Related Disorders | 2019 |